The PD-L1-positive brain metastasis group had a significantly shorter brain-specific disease-free survival than the PD-L1-negative resected brain-metastatic NSCLC brain metastasis group (p < 0.05) [127]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.